The Colorado Center for Nanomedicine and Nanosafety will promote collaborative effort, stimulate learning, and advance multidisciplinary research and education in the areas of basic and applied nanomedicine and nanosafety, between academic labs and the local and national biotech and pharma companies.
Sponsors: Skaggs School of Pharmacy and Pharmaceutical Sciences, ALSAM foundation
Mission and Goals
- The CCNN was established within the Skaggs School of Pharmacy and Pharmaceutical Sciences in 2016.
- The CCNN will include members from University of Colorado Anschutz Medical Campus, other University of Colorado campuses and any other interested, qualifying professionals from the State of Colorado.
- The CCNN will lead the discovery of new diagnostics and therapeutic approaches that could be translated and commercialized.
- The CCNN will provide intellectual, technical and financial resources in the research and service areas of nanotechnology and nanomedicine to collaborators from a diverse range of disciplines.
- The CCNN will promote the penetration of nanomedicine and nanosafety into clinical and translational research in order to foster future development of treatments and diagnostics and improve the safety and use of nanomedicines.
- The CCNN will increase the awareness of safety and toxicity issues associated with nanomaterials and the role of environmental nanomaterials in the pathology of disease.
- The CCNN will enhance the national and international visibility of the current efforts at the University of Colorado in the field of nanomedicine and nanosafety.
- The CCNN will provide training and education of clinical and basic scientists.